Genetic and phenotypic differences among Enterococcus faecalis clones from intestinal colonisation and invasive disease

Clinical Microbiology and Infection

Volumn 12, Issue 12, 2006, Pages 1193-1198

  Ruiz Garbajosa, P ^a   Canton R ^a   Pintado, V ^a   Coque, T M ^a   Willems, R ^b,c   Baquero, F ^a   del Campo, Rosa ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antimicrobial resistance; Colonisation; Enterococcus faecalis; Invasive disease; Population structure; Virulence genes

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BACTERIAL PROTEIN; BACTERIOCIN; CHLORAMPHENICOL; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; HEMOLYSIN; KANAMYCIN; LINEZOLID; MINOCYCLINE; MOXIFLOXACIN; PROTEIN ACE; PROTEIN AGG; PROTEIN CYLA; PROTEIN ESP; PROTEIN GELE; PROTEINASE; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; FEMALE; GENE EXPRESSION; HUMAN; INTENSIVE CARE UNIT; INTESTINE INFECTION; MALE; MOLECULAR CLONING; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; STRAIN DIFFERENCE; VOLUNTEER;

ENTEROCOCCUS FAECALIS;

EID: 33751113541     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01533.x     Document Type: Article

References (30)

1. Bonilla HF, Zervos MJ, Lyons MJ et al. Colonization with vancomycin-resistant Enterococcus faecium: Comparison of a long-term care unit with an acute-care hospital. Infect Control Hosp Epidemiol 1997; 18: 333-339.
2. Handweger S, Raucher B, Altarac D et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicllin and gentamicin. Clin Infect Dis 1993; 16: 750-755.
3. Karanfil LV, Murphy M, Josephson A et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992; 13: 195-200.
4. Malani PN, Thal LA, Donabedian SM et al. Molecular analysis of vancomycin-resistant Enterococcus faecalis from Michigan hospitals during a 10 year period. J Antimicrob Chemother 2002; 49: 841-843.
5. Van den Bogaard AE, Jense LB, Stobberingh EE. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med 1997; 337: 1558-1559.
6. Willems RJL, Top J, Van Santen M et al. Global emergence of vancomycin-resistant Enterococcus faecium is caused by the clonal spread of a distinct nosocomially-adapted genetic complex. Emerg Infect Dis 2005; 11: 821-828.
7. Mundy LM, Sahm DF, Gilmore M. Relationships between enterococcal virulence and antimicrobial resistance. Clin Microbiol Rev 2000; 13: 513-522.
8. Ben Omar N, Castro A, Lucas R et al. Functional and safety aspects of enterococci isolated from different Spanish foods. System Appl Microbiol 2004; 27: 118-130.
9. Eaton TJ, Gasson MJ. Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol 2001; 67: 1628-1635.
10. Franz CMAP, Muscholi-Silberhorn AB, Yousif NMK et al. Incidence of virulence factors and antibiotic resistance among enterococci isolated from food. Appl Environ Microbiol 2001; 67: 4385-4389.
11. Semedo T, Almeida-Santos M, Martins P et al. Comparative study using type strains and clinical and food isolates to examine haemolytic activity and occurrence of the cyl operon in enterococci. J Clin Microbiol 2003; 41: 2569-2576.
12. Austin DJ, Bonten MJ, Weinstein RA et al. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of the control programs. Proc Natl Acad Sci USA 1999; 96: 6908-6913.
13. Bonten MJ, Austin DJ, Lipsitch M. Understanding the spread of antibiotic resistant pathogens in hospitals: Mathematical models as tools for control. Clin Infect Dis 2001; 33: 1739-1746.
14. Del Campo R, Tenorio C, Zarazaga M et al. Detection of a single vanA -containing E. faecalis clone in hospitals of different regions in Spain. J Antimicrob Chemother 2001; 48: 746-747.
15. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003; 51 (suppl S3): 13-21.
16. Peset V, Tallón P, Sola C et al. Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species. Eur J Clin Microbiol Infect Dis 2000; 19: 742-749.
17. Velasco D, Pérez S, Domínguez MA et.al. Description of a nosocomial outbreak of infection caused by a vanA -containing strain of Enterococcus faecalis in La Coruña, Spain. J Antimicrob Chemother 2004; 53: 892-893.
18. Macia MD, Juan C, Oliver A et al. Molecular characterization of a glycopetide-resistant Enterococcus faecalis outbreak in an intensive care unit. Enferm Infecc Microbiol Clin 2005; 23: 460-463.
19. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard CLSI M7-A5. Wayne, PA: CLSI, 2000.
20. National Nosocomial Infections Surveillance. System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27: 520-532.
21. Del Campo R, Tenorio C, Jiménez-Díaz R et al. Bacteriocin production in vancomycin-resistant and vancomycin-susceptible Enterococcus isolates of different origins. Antimicrob Agents Chemother 2001; 45: 905-912.
22. Descheemaeker P, Lammens C, Pot B et al. Evaluation of arbitrarily primed PCR analysis and pulsed-field gel electrophoresis of large genomic DNA fragments for identification of enterococci important in human medicine. Int J Syst Bacteriol 1997; 47: 555-561.
23. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
24. Duck WM, Steward CD, Banerjee SN et al. Optimization of computer software settings improves accuracy of pulsed-field gel electrophoresis macrorestriction fragment pattern analysis. J Clin Microbiol 2003; 41: 3035-3042.
25. Malani PN, Kauffman CA, Zervos MJ Enterococcal disease, epidemiology, and treatment. In: Gilmore MS, Clewell DB, Courvalin PM, Dunny GM, Murray BM, Rice, LB, eds, The enterococci: Pathogenesis, molecular biology, and antibiotic resistance. Washington DC: ASM Press, 2002; 385-408.
26. Aarestrup FM, Butaye P, Witte W. Nonhuman reservoirs of enterococci. In: Gilmore MS, Clewell DB, Courvalin PM, Dunny GM, Murray BM, Rice LB, eds, The enterococci: Pathogenesis, molecular biology, and antibiotic resistance. Washington DC: ASM Press, 2002; 55-99.
27. Haas W, Shepard BD, Gilmore MS. Novel two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction. Nature 2002; 415: 84-87.
28. Gilmore MS, Segarra RA, Booth MC et.al. Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants. J Bacteriol 1994; 176: 7335-7734.
29. Hällgren A, Abednazari H, Ekdahl C et al. Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems. J Antimicrob Chemother 2001; 48: 53-62.
30. Hällgren A, Saeedi B, Nilsson M et al. Genetic relatedness among Enterococcus faecalis with transposon-mediated high-level gentamicin resistance in Swedish intensive care units. J Antimicrob Chemother 2003; 52: 162-167.